The needs of patients receiving depot antipsychotic medication within primary care

被引:3
|
作者
Phelan, M
Mirza, L
机构
[1] Acad Ctr, St Bernards Wing, Uxbridge UB1 3EU, Middx, England
[2] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Psychiat, London, England
关键词
depot antipsychotic; needs assessment; schizophrenia;
D O I
10.1093/fampra/20.2.126
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Depot antipsychotic medication is a vital treatment for many people with schizophrenia. Many patients receive this medication from primary care, and have little or no contact with specialist mental health services. Objective. The aim of the present study was to compare the characteristics and needs of patients receiving depot medication within primary care with those receiving their medication from specialist mental health services. Methods. A total of 58 patients were identified from four primary care teams. Data were collected from medical records, and staff interviews were conducted using standardized interview schedules. Results. Patients receiving medication from primary care had more than twice as many health and social needs compared with those receiving medication from specialist services. Conclusions. There are advantages for patients to receive depot medication from primary care, but the needs of the patients must be reviewed regularly, and primary care staff must have easy access to specialist mental health services.
引用
收藏
页码:126 / 128
页数:3
相关论文
共 50 条
  • [21] Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication
    Keenan, Rawiri
    Chepulis, Lynne
    Ly, Joanna
    Carter, Sally
    Lao, Chunhuan
    Asim, Muhammad
    Bhat, Abhijit
    Deo, Shivam
    Lim, Kee Ping
    Mohammed, Ruzaimah
    Scarlet, Sophie
    Lawrenson, Ross
    JOURNAL OF PRIMARY HEALTH CARE, 2020, 12 (01) : 29 - 34
  • [22] Why change injection sites for depot antipsychotic medication?
    Cox, Alicia
    Emmerson, Brett
    Collyer, Bruce
    Scott, James
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 (08): : 794 - 794
  • [23] Community psychiatric nurses' attitudes to depot antipsychotic medication
    Patel, M
    De Zoysa, N
    David, AS
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 342 - 342
  • [24] Financial incentives for antipsychotic depot medication: ethical issues
    Claassen, Dirk
    JOURNAL OF MEDICAL ETHICS, 2007, 33 (04) : 189 - 193
  • [25] Use of depot antipsychotic medications for medication nonadherence in schizophrenia
    West, Joyce C.
    Marcus, Steven C.
    Wilk, Joshua
    Countis, Lisa M.
    Regier, Darrel A.
    Olfson, Mark
    SCHIZOPHRENIA BULLETIN, 2008, 34 (05) : 995 - 1001
  • [26] Patients' attitudes to antipsychotic depot medication: adherence, extrapyramidal side effects and needle anxiety
    Patel, M. X.
    DeZoysa, N.
    Bernadt, M.
    David, A. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S369 - S369
  • [27] PHYSICAL HEALTH MONITORING OF PATIENTS TAKING ANTIPSYCHOTIC MEDICATION IN PRIMARY AND SECONDARY CARE: A COMPLETE AUDIT
    Jesudason, P.
    Narayan, V.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [28] Systematic review of patient and nurse attitudes to depot antipsychotic medication
    Walburn, J
    Gray, R
    Gournay, K
    Quraishi, S
    David, AS
    BRITISH JOURNAL OF PSYCHIATRY, 2001, 179 : 300 - 307
  • [29] ATTITUDES OF FRENCH PSYCHIATRISTS TOWARD ANTIPSYCHOTIC DEPOT MEDICATION IN SCHIZOPHRENIA
    Charpeaud, T.
    Samalin, L.
    Blanc, O.
    Llorca, P-M.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [30] DEPOT ANTIPSYCHOTIC MEDICATION IN THE MANAGEMENT OF BEHAVIORAL AND PSYCHOTIC SYMPTOMS IN DEMENTIA
    HOWARD, R
    LEVY, R
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1993, 8 (02) : 111 - 113